ID: 5
InChIKey: LUKBXSAWLPMMSZ-OWOJBTEDSA-N SMILES: C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)O
biological descriptors:
CFTR relevance: CFTR correctorCategory:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment Apical membrane & subapical compartment
CID is 445154
synonyms found at PubChem are:
resveratrol, 501-36-0, trans-resveratrol, 3,4',5-Trihydroxystilbene, (E)-5-(4-Hydroxystyryl)benzene-1,3-diol, 3,5,4'-Trihydroxystilbene, (E)-resveratrol, 3,4',5-Stilbenetriol, Resvida, 3,4',5-Trihydroxy-trans-stilbene, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol, SRT-501, SRT501, Resveratol, SRT 501, 3,5,4'-Trihydroxy-trans-stilbene, 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol, 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol, 3,4',5-trihydroxy-stilbene, Resveratrol, natural, UNII-Q369O8926L, CHEBI:45713, trans-3,4',5-trihydroxystilbene, (E)-5-(p-Hydroxystyryl)resorcinol, trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene, 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol, CHEMBL165, NSC 327430, (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol, MLS000069735, 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-, LUKBXSAWLPMMSZ-OWOJBTEDSA-N, KUC104385N, PREVENTION 8 (RESVERATROL), C14H12O3, trans-3,4',5 - trihydroxystilbene, NSC327430, KSC-10-164, Q369O8926L, 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol, RM-1812, trans-3,4′,5-Trihydroxystilbene, SMR000058206, R 5010, DSSTox_CID_11980, DSSTox_RID_78898, DSSTox_GSID_31980, CU-01000001503-3, (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol, (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol, 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-, MFCD00133799, STL, SR-01000000163, 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol, CHEBI:27881, CCRIS 8952, HSDB 7571, 3fts, 4jaz, 4qer, Resveratrol, E-, Resveratrol,(S), Stilbene, 2f, TaxusChinensisiRehd, NCGC00015894-02, CAS-501-36-0, Prestwick_619, Trans-3,4&prime, Resveratrol, trans-, Resveratrol, synthetic, Opera_ID_586, AC1L9HIC, Prestwick2_000508, Prestwick3_000508, Spectrum5_000552, D0U3EP, Lopac0_001111, REGID_for_CID_6240, SCHEMBL19425, BSPBio_000435, BSPBio_001114, BSPBio_003461, MLS001055357, MLS001076538, MLS001424228, MLS002207121, MLS002222231, ARONIS24568, SPECTRUM1502223, BPBio1_000479, cid_445154, GTPL8741, SGCUT00007, trans-Stilbene-3,4',5-triol, ZINC6787, Resveratrol, analytical standard, DTXSID4031980, REGID_for_CID_445154, BDBM23926, Resveratrol, >=99% (HPLC), BBC/741, BIK9013, 2l98, MolPort-002-499-801, BCPP000091, HMS1362H15, HMS1569F17, HMS1792H15, HMS1921N04, HMS1990H15, HMS2052I09, HMS2096F17, HMS2232A18, HMS3263O04, HMS3403H15, HMS3649A20, ACT09778, BCP01416, to_000079, ZX-AS004941, ZX-AT013797, Tox21_110257, Tox21_201374, Tox21_303376, Tox21_501111, ABP000376, AC-727, AN-865, BBL028252, BS0159, CCG-38874, CR-003, GP2549, GP5884, LMPK13090005, s1396, SBB055452, STL146386, AKOS005720936, Tox21_110257_1, ACN-034773, API0000480, CS-1050, DB02709, KS-5047, LP01111, LS-2146, MCULE-5678456463, NC00349, NSC-327430, OR46018, RP17549, SDCCGMLS-0002998.P003, IDI1_002152, Resveratrol solution, 100 mM in DMSO, NCGC00017352-05, NCGC00017352-06, NCGC00017352-07, NCGC00017352-08, NCGC00017352-09, NCGC00017352-10, NCGC00017352-11, NCGC00017352-12, NCGC00017352-13, NCGC00017352-14, NCGC00017352-15, NCGC00017352-16, NCGC00017352-17, NCGC00017352-18, NCGC00017352-19, NCGC00017352-24, NCGC00024003-00, NCGC00024003-04, NCGC00024003-05, NCGC00024003-06, NCGC00024003-07, NCGC00024003-08, NCGC00024003-09, NCGC00024003-10, NCGC00024003-11, NCGC00024003-12, NCGC00024003-13, NCGC00024003-14, NCGC00257465-01, NCGC00258925-01, NCGC00261796-01, 375823-41-9, 4CN-0696, AJ-08292, AK-39118, AS-12413, BC202036, BR-39118, CC-34242, CJ-00111, CPD000058206, HY-16561, KB-02515, SAM001246888, SC-11924, ST057251, SY014849, ZB000650, AB0006623, AX8004672, ST2408097, TL8003323, EU-0101111, FT-0082623, N1848, R0071, Resveratrol, Vetec(TM) reagent grade, 98%, 01R360, C03582, J10118, N88795, 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol, AB00052942-29, AB00052942_31, A827984, 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol, I06-0437, SR-01000000163-3, SR-01000000163-4, SR-01000000163-9, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol, 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol, 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol, 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol, BRD-K25591257-001-01-2, BRD-K80738081-001-06-2, BRD-K80738081-001-07-0, BRD-K80738081-001-09-6, BRD-K80738081-001-10-4, BRD-K80738081-001-23-7, SR-01000000163-10, SR-01000000163-11, SR-01000000163-16, (E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene, (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene, 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol, Resveratrol, certified reference material, TraceCERT(R), 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-, Resveratrol, European Pharmacopoeia (EP) Reference Standard, 533C1DA0-4104-42B5-9D32-9265F40857E4, trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard, 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol, (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol, InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1, trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol
ID: 16
InChIKey: JWZZKOKVBUJMES-UHFFFAOYSA-N SMILES: CC(C)NCC(C1=CC(=C(C=C1)O)O)O
biological descriptors:
CFTR relevance: stimulates Cl- conductance as agonist of β2 adrenergic receptorCategory:
Influence on CFTR function enhances CFTR function
Order of interaction indirect
subcellular compartment Apical membrane & subapical compartment
CID is 3779
synonyms found at PubChem are:
isoproterenol, Isoprenaline, Isoprenalin, Norisodrine, Novodrin, Isopropydrin, Isopropylarterenol, Asiprenol, Assiprenol, Bellasthman, Respifral, Aludrin, Aludrine, Asmalar, Isadrine, N-Isopropylnoradrenaline, Bronkephrine, Isonorene, Isopropyladrenaline, Lomupren, Neodrenal, Proternol, N-Isopropylnorepinephrine, Isopropylnorepinephrine, 7683-59-2, neo-Epinine, Isonorin, Isorenin, Saventrine, Isopropylnoradrenaline, Isopropyl noradrenaline, Racemic isoprenaline, dl-Isadrine, Isuprel, Racemic isoproterenol, (+-)-Isoproterenol, Vapo-N-iso, Epinephrine isopropyl homolog, Isoprenalinum, Isoproterenolum, Aleudrine, Isupren, (+-)-Isoprenaline, dl-Ipr, Isoprenalina, Isadrin, Isoproterenol [JAN], Dihydroxyphenylethanolisopropylamine, WIN 5162, DL(+-)-Isoproterenol, Medihaler-ISO, dl-Isopropylnoradrenaline, DL-Isopropylnorepinephrine, dl-N-Isopropylnoradrenaline, Isoprenalinum [INN-Latin], Isoprenalina [INN-Spanish], Isoproterenol Chloride, 1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol, ICI 46399, l-Isoproterenol, d-Isoprenaline, d-Isoproterenol, alpha-(Isopropylaminomethyl)protocatechuyl alcohol, Isuprel Mistometer, N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine, (S)-Isoproterenol, (+)-Isoprenaline, d-Isopropylarterenol, Aleudrin, 1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol, Isoprenaline (INN), ISOPROP, CCRIS 3081, 4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol, l-Isopropylnoradrenaline, NSC 9975, EINECS 231-687-7, NSC 33791, (S)-(+)-Isoproterenol, Isoproterenol sulfate, Isopropylaminomethyl-3,4-dihydroxyphenyl carbinol, CHEMBL434, d-N-Isopropylnorepinephrine, 1,2-Benzenediol, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-, BRN 2213857, 3,4-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol, 4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol, CHEBI:64317, 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, JWZZKOKVBUJMES-UHFFFAOYSA-N, (S)-Isoprenaline, Isopropylaminomethyl(3,4-dihydroxyphenyl)carbinol, NSC33791, (+)-Isoproterenol, Isoprenaline [INN], Protocatechuyl alcohol, alpha-(isopropylaminomethyl)-, DL-ISOPROTERENOL, NCGC00015558-06, 3,4-Dihydroxy-.alpha.-(isopropylaminomethyl)-benzyl alcohol, Protocatechuyl alcohol,-, Isoprenaline sulfate, Isuprel (TN), DSSTox_CID_3175, 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, (+-)-, BENZYL ALCOHOL, 3,4-DIHYDROXY-alpha-((ISOPROPYLAMINO)METHYL)-, (+-)-, DSSTox_RID_76904, DSSTox_GSID_23175, 149-53-1, .alpha.-(Isopropylaminomoethyl)protocatechuyl alcohol, 4-(1-Hydroxy-2(isopropylamino)ethyl)-benzene 1,2-diol, 4-(1-Hydroxy-2-(isopropylamino)ethyl)benzene-1,2-diol, 3,4-dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol, WLN: QR BQ DYQ1MY1&1, 3,4-Dihydroxy-.alpha.-[(isopropylamino)methyl]benzyl alcohol, 4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}benzene-1,2-diol, Benzyl alcohol, 3,4-dihydroxy-alpha-((isopropylamino)methyl)-, CAS-7683-59-2, 1, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-, 4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol, 4-{1-hydroxy-2-[(methylethyl)amino]ethyl}benzene-1,2-diol, Benzyl alcohol,4-dihydroxy-.alpha.-[(isopropylamino)methyl]-, Isoproterenol-l, Isoproterenol;, Isoprenalinesulphate, Isoproterenol (-), Isoproterenol,(+), DL-isoprenaline HCl, ISOPROTERONOL, Isuprel (Salt/Mix), Izadrin (Salt/Mix), Euspiran (Salt/Mix), (+/-)-isoprenaline, (+/-)-isoproterenol, Spectrum_000949, AC1L1GOZ, AC1Q1QBS, 6700-39-6, Prestwick0_001097, Prestwick1_001097, Prestwick2_001097, Spectrum2_001061, Spectrum3_000474, Spectrum4_000024, Spectrum5_000880, (.+/-.)-Isoprenaline, (.+/-.)-Isoproterenol, D0I8FI, D0IF0C, D0P1IS, SCHEMBL4165, DL(.+/-.)-Isoproterenol, Lopac0_000711, Oprea1_009434, BSPBio_002208, GTPL536, KBioGR_000427, KBioSS_001429, 3-13-00-02387 (Beilstein Handbook Reference), DivK1c_000894, SPBio_001042, SPBio_003057, SGCUT00015, BENZYL ALCOHOL, 3,4-DIHYDROXY-alpha-((ISOPROPYLAMINO)METHYL)-, (+)-, DTXSID4023175, BDBM25392, KBio1_000894, KBio2_001429, KBio2_003997, KBio2_006565, KBio3_001428, NSC9975, NINDS_000894, HMS2089A12, BCP09043, NSC-9975, to_000062, (A+/-)-Isoproterenol hydrochloride, Tox21_110172, AS1409, NSC-33791, PDSP1_001425, PDSP2_001409, SBB005855, AKOS015913894, Tox21_110172_1, API0006523, CCG-204727, CCG-204796, DB01064, MCULE-6061231962, IDI1_000894, NCGC00015558-04, NCGC00015558-05, NCGC00015558-07, NCGC00015558-08, NCGC00015558-09, NCGC00015558-10, NCGC00015558-11, NCGC00015558-12, NCGC00015558-14, NCGC00016665-02, NCGC00025274-03, NCGC00025274-04, NCGC00162220-01, LS-42866, LS-42868, LS-42869, ST077771, SBI-0050689.P004, FT-0724367, C07056, D08090, EN300-148243, AB00053487-09, AB00053487-10, AB00053487_11, AB00053487_12, 683I592, alpha-(Isopropylaminomoethyl)protocatechuyl alcohol, L000936, .alpha.-(Isopropylaminomethyl)protocatechuyl alcohol, I14-45263, Protocatechuyl alcohol,.alpha.-(isopropylamino-methyl),-, 3,4-dihydroxy-alpha-[(isopropylamino)methyl]-benzyl alcohol, 4-[1-Hydroxy-2-(isopropylamino)ethyl]-1,2-benzenediol #, N-Isopropyl-.beta.-dihydroxyphenyl-.beta.-hydroxyethylamine, 4-[1-hydroxy-2-(isopropylamino)ethyl]pyrocatechol;hydrochloride, 4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,2-diol, 4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,2-diol, 2, Benzyl alcohol, 3,4-dihydroxy-.alpha.-((isopropylamino)methyl)-, 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)- (9CI), 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-(9CI), 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, (S)-, 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, (S)-(9CI), 46388-38-9
ID: 1963
InChIKey: RKUNBYITZUJHSG-PJPHBNEVSA-N SMILES: CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
biological descriptors:
CFTR relevance: salivary secretion inhibitorCategory:
Influence on CFTR function none
Order of interaction unknown
subcellular compartment unknown
CID is 174174
synonyms found at PubChem are:
ATROPINE, Tropine tropate, dl-Hyoscyamine, Atropin, Atropen, dl-Tropyltropate, Atropinol, Atropina, Eyesules, Isopto-atropine, Troyl tropate, hyoscyamine, Atropin [German], 51-55-8, Atropina [Italian], Atropin-flexiolen, (+,-)-Tropyl tropate, DL-Tropyl tropate, (+-)-hyoscyamine, Tropine, tropate (ester), (+-)-atropine, Tropic acid, ester with tropine, Cytospaz, (+/-)-Atropine, Atropine sulfate, CCRIS 3080, Atropine (USP), Atropine [BAN], Isopto Atropine, (+/-)-Hyoscyamine, Tropic acid, 3-alpha-tropanyl ester, Belladenal, Atropair, Atrosulf, Atropt, Minims, Urised, Minims Atropine, Atropine Care, HSDB 2199, Bellergal-S, Neo-Diophen, Ocu-Tropine, DL-Tropanyl 2-hydroxy-1-phenylpropionate, I-Tropine, Anaspaz, Atropen (TN), 2-Phenylhydracrylic acid 3-alpha-tropanyl ester, L-Hyoscyamine, Protamine & Atropine, AI3-60219, beta-Phenyl-gamma-oxypropionsaure-tropyl-ester [German], (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate, 1alphaH,5alphaH-Tropan-3alpha-ol (+-)-tropate (ester), beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester [German], (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate, tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate, EINECS 200-104-8, Tropine (+/-)-tropate, atropinum sulphuricum, 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate, Atropine Sulfate S.O.P., Daturine, Hyospaz, Hyosyne, Levbid, l-Atropine, MLS000069795, Symax Duotab, (+)-HYOSCYAMINE, Hyoscyamine sulfate, 1-Hyoscyamine, Levsinex SR, CHEBI:16684, Levsin SL, Symax SL, Symax SR, 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate, (+)-Atropine, [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate, Hyoscyamine [BAN], endo-(+/-)-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, d1-hyoscyamine, R-(+)-Hyoscyamine, atropinium cation, Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo(3,2,1)oct-3-yl ester, endo-(+-)-, NCGC00017333-03, SMR000058248, atropinium(1+), (S)-(-)-Hyoscyamine, DSSTox_CID_113, 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester) (8CI), Atropine Sulfate Ansyr Plastic Syringe, AB00694549-11, [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate, DSSTox_RID_75375, DSSTox_GSID_20113, Hyocyamine, Buwecon, Donnamar, Egacene, Gastrosed, Levsinex, Neoquess, Peptard, Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, Benzeneacetic acid, alpha-(hydroxymethyl)-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+-)-, Atropine, 3(S)-endo-Isomer, Symax, l-Hyopscyamine, L-Hyoscamine, Scopolia extract, Tropine, (-)-tropate (ester), C17H23NO3, 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester), Hyoscyamine (USP), (-)-Tropic Acid Ester with Tropine, 8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropionate, Donnagel, Egazil, Nulev, b eta-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, CAS-51-55-8, Tropic acid, (-)-, ester with tropine, Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+-)-, Tropine, (-)-tropate, NP-010662, Atropine [USP:BAN], alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, HYOSCYAMINE HCl, Mydriasine, Atropinum, ropine tropate, MFCD00022622, (1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate, Hyospasmol (TN), Cystospaz (TN), NCGC00159345-02, 3-tropoyloxytropane, Donnamar (TN), Neoquess (TN), 13269-35-7, Anaspaz (TN), Buwecon (TN), Levbid (TN), Levsin (TN), HyoMax (TN), Symax (TN), NuLev (TN), H 9002, (3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-azoniabicyclo[3.2.1]octane, Opera_ID_1088, beta-Phenyl-gamma-oxypropionsaure-tropyl-ester, bmse000649, D0RD5W, D0RG3O, beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester, AC1L5AX3, AC1Q3XL2, SCHEMBL2812, Atropine, analytical standard, GTPL320, MLS001148094, MLS002695888, CHEMBL475124, CHEMBL517712, cid_174174, MEGxp0_001878, DTXSID4020113, ACon1_000046, CHEBI:78734, (1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate, Atropine, >=95.0% (NT), MolPort-001-742-593, RKUNBYITZUJHSG-SPUOUPEWSA-N, BDBM200229, HMS2089A16, HMS2231G17, HMS3259M13, BCP15060, HY-B1205, OIN, Atropine, >=99% (TLC), powder, Tox21_110816, Tox21_111590, Tox21_200487, BDBM50403547, GP2470, SBB005985, AKOS015955538, CS-4834, DB00572, LS-7203, NC00493, OR22908, RL00080, NCGC00017333-02, NCGC00017333-04, NCGC00017333-05, NCGC00017333-06, NCGC00142514-01, NCGC00142514-03, NCGC00258041-01, NCGC00385525-01, Benzeneacetic acid, alpha-(hydroxymethyl)- 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester endo-(+-)-, CPD001906768, SAM002554885, ST057178, Atropine, meets USP testing specifications, TR-000361, C1504, FT-0602865, FT-0627165, C01479, D00113, AB00694549-12, AB00694549_14, rac-tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate, BRD-A27290375-001-01-8, BRD-A27290375-330-01-1, Atropine, European Pharmacopoeia (EP) Reference Standard, [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate, [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate, alpha-Hydroxymethylphenylacetic acid (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octane-3-yl ester, Atropine for peak identification, European Pharmacopoeia (EP) Reference Standard, rac-(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate, (1beta,3alpha,5beta)-3-[(3-Hydroxy-1-oxo-2-phenylpropyl)oxy]-8-methyl-8-azabicyclo[3.2.1]octane, 78597-12-3, Benzeneacetic acid, alpha-(hydroxymethyl)- (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, Benzeneacetic acid, alpha-(hydroxymethyl)-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+/-)-, Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo [3.2.1]oct-3-yl ester, endo-(+/-)-, Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester endo-(+-)-, endo-( inverted exclamation markA)-|A-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester